TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Norsk Diabetessenter For Behandling og Opplæring
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,187
|
1,215
|
1,093 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-58
|
37
|
17 |
Total assets |
1,436
|
1,599
|
1,460 |
Current assets |
959
|
1,081
|
954 |
Current liabilities |
193
|
225
|
192 |
Equity capital |
1,244
|
1,374
|
1,268 |
- share capital |
10
|
11
|
10 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.6%
|
85.9%
|
86.8% |
Turnover per employee | |||
Profit as a percentage of turnover |
-4.9%
|
3.0%
|
1.6% |
Return on assets (ROA) |
-4.0%
|
2.3%
|
1.2% |
Current ratio |
496.9%
|
480.4%
|
496.9% |
Return on equity (ROE) |
-4.7%
|
2.7%
|
1.3% |
Change turnover |
36
|
62
|
-40 |
Change turnover % |
3%
|
5%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.